621 related articles for article (PubMed ID: 20234369)
21. Detection of miR-106a in gastric carcinoma and its clinical significance.
Xiao B; Guo J; Miao Y; Jiang Z; Huan R; Zhang Y; Li D; Zhong J
Clin Chim Acta; 2009 Feb; 400(1-2):97-102. PubMed ID: 18996365
[TBL] [Abstract][Full Text] [Related]
22. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
[TBL] [Abstract][Full Text] [Related]
23. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
Li BS; Zhao YL; Guo G; Li W; Zhu ED; Luo X; Mao XH; Zou QM; Yu PW; Zuo QF; Li N; Tang B; Liu KY; Xiao B
PLoS One; 2012; 7(7):e41629. PubMed ID: 22860003
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profiling of human gastric cancer.
Yao Y; Suo AL; Li ZF; Liu LY; Tian T; Ni L; Zhang WG; Nan KJ; Song TS; Huang C
Mol Med Rep; 2009; 2(6):963-70. PubMed ID: 21475928
[TBL] [Abstract][Full Text] [Related]
25. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
Emami SS; Nekouian R; Akbari A; Faraji A; Abbasi V; Agah S
J Cancer Res Ther; 2019; 15(1):115-119. PubMed ID: 30880765
[TBL] [Abstract][Full Text] [Related]
28. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients.
Zhou H; Xiao B; Zhou F; Deng H; Zhang X; Lou Y; Gong Z; Du C; Guo J
Biomarkers; 2012 Mar; 17(2):104-10. PubMed ID: 22263628
[TBL] [Abstract][Full Text] [Related]
29. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer.
Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X
Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261
[TBL] [Abstract][Full Text] [Related]
30. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis.
Zhou X; Zhu W; Li H; Wen W; Cheng W; Wang F; Wu Y; Qi L; Fan Y; Chen Y; Ding Y; Xu J; Qian J; Huang Z; Wang T; Zhu D; Shu Y; Liu P
Sci Rep; 2015 Jun; 5():11251. PubMed ID: 26059512
[TBL] [Abstract][Full Text] [Related]
32. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
Fang C; Zhu DX; Dong HJ; Zhou ZJ; Wang YH; Liu L; Fan L; Miao KR; Liu P; Xu W; Li JY
Ann Hematol; 2012 Apr; 91(4):553-9. PubMed ID: 21987025
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease.
Soeda S; Ohyashiki JH; Ohtsuki K; Umezu T; Setoguchi Y; Ohyashiki K
Int J Mol Med; 2013 Mar; 31(3):533-9. PubMed ID: 23338559
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers.
Zhang R; Wang W; Li F; Zhang H; Liu J
Med Oncol; 2014 Oct; 31(10):243. PubMed ID: 25218271
[TBL] [Abstract][Full Text] [Related]
35. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.
Madhavan D; Zucknick M; Wallwiener M; Cuk K; Modugno C; Scharpff M; Schott S; Heil J; Turchinovich A; Yang R; Benner A; Riethdorf S; Trumpp A; Sohn C; Pantel K; Schneeweiss A; Burwinkel B
Clin Cancer Res; 2012 Nov; 18(21):5972-82. PubMed ID: 22952344
[TBL] [Abstract][Full Text] [Related]
36. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival.
Silva J; García V; Zaballos Á; Provencio M; Lombardía L; Almonacid L; García JM; Domínguez G; Peña C; Diaz R; Herrera M; Varela A; Bonilla F
Eur Respir J; 2011 Mar; 37(3):617-23. PubMed ID: 20595154
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
[TBL] [Abstract][Full Text] [Related]
38. Serum miR-574-5p: a prognostic predictor of sepsis patients.
Wang H; Meng K; Chen Wj; Feng D; Jia Y; Xie L
Shock; 2012 Mar; 37(3):263-7. PubMed ID: 22344312
[TBL] [Abstract][Full Text] [Related]
39. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M
Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies.
Wu L; Zhou H; Lin H; Qi J; Zhu C; Gao Z; Wang H
Reproduction; 2012 Mar; 143(3):389-97. PubMed ID: 22187671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]